Details for New Drug Application (NDA): 076870
✉ Email this page to a colleague
NDA 076870 describes ALLOPURINOL SODIUM, which is a drug marketed by Gland and Hikma and is included in two NDAs. It is available from three suppliers. Additional details are available on the ALLOPURINOL SODIUM profile page.
The generic ingredient in ALLOPURINOL SODIUM is allopurinol sodium. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the allopurinol sodium profile page.
The generic ingredient in ALLOPURINOL SODIUM is allopurinol sodium. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the allopurinol sodium profile page.
Summary for 076870
| Tradename: | ALLOPURINOL SODIUM |
| Applicant: | Hikma |
| Ingredient: | allopurinol sodium |
| Patents: | 0 |
Pharmacology for NDA: 076870
| Mechanism of Action | Xanthine Oxidase Inhibitors |
Suppliers and Packaging for NDA: 076870
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ALLOPURINOL SODIUM | allopurinol sodium | INJECTABLE;INJECTION | 076870 | ANDA | Hikma Pharmaceuticals USA Inc. | 0143-9533 | 0143-9533-01 | 1 VIAL in 1 BOX, UNIT-DOSE (0143-9533-01) / 25 mL in 1 VIAL |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 500MG BASE/VIAL | ||||
| Approval Date: | Aug 26, 2004 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
